The Company is pleased to announce its prototype diagnostic test for oesophageal adenocarcinoma has...
Proteomics set for revenue boost after launching two products
After going commercial in August and September with two medical diagnostic products, Proteomics International is now set to see a growing pipeline of revenues.
The September 2025 quarter saw the company make significant progress in commercialisation, clinical certification, and pipeline development, supported by a robust financial position.
